Annual Cash & Cash Equivalents
$69.75 M
-$106.30 M-60.38%
December 31, 2024
Summary
- As of March 13, 2025, SWTX annual cash & cash equivalents is $69.75 million, with the most recent change of -$106.30 million (-60.38%) on December 31, 2024.
- During the last 3 years, SWTX annual cash & cash equivalents has fallen by -$34.21 million (-32.91%).
- SWTX annual cash & cash equivalents is now -78.71% below its all-time high of $327.65 million, reached on December 31, 2019.
Performance
SWTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$69.75 M
-$14.71 M-17.41%
December 31, 2024
Summary
- As of March 13, 2025, SWTX quarterly cash and cash equivalents is $69.75 million, with the most recent change of -$14.71 million (-17.41%) on December 31, 2024.
- Over the past year, SWTX quarterly cash and cash equivalents has dropped by -$10.15 million (-12.70%).
- SWTX quarterly cash and cash equivalents is now -85.36% below its all-time high of $476.43 million, reached on September 30, 2022.
Performance
SWTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SWTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.4% | -12.7% |
| 3 y3 years | -32.9% | -12.7% |
| 5 y5 years | -78.7% | -12.7% |
SWTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.4% | +3.4% | -85.4% | +3.4% |
| 5 y | 5-year | -78.7% | +3.4% | -85.4% | +3.4% |
| alltime | all time | -78.7% | +579.1% | -85.4% | +52.8% |
SpringWorks Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $69.75 M(-60.4%) | $69.75 M(-17.4%) |
| Sep 2024 | - | $84.46 M(+5.7%) |
| Jun 2024 | - | $79.90 M(-32.3%) |
| Mar 2024 | - | $118.03 M(-33.0%) |
| Dec 2023 | $176.05 M(+160.9%) | $176.05 M(+78.0%) |
| Sep 2023 | - | $98.89 M(-14.0%) |
| Jun 2023 | - | $115.00 M(+12.3%) |
| Mar 2023 | - | $102.40 M(+51.7%) |
| Dec 2022 | $67.49 M(-35.1%) | $67.49 M(-85.8%) |
| Sep 2022 | - | $476.43 M(+584.8%) |
| Jun 2022 | - | $69.57 M(-15.1%) |
| Mar 2022 | - | $81.93 M(-21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $103.96 M(-29.3%) | $103.96 M(+10.8%) |
| Sep 2021 | - | $93.85 M(+11.0%) |
| Jun 2021 | - | $84.57 M(-11.4%) |
| Mar 2021 | - | $95.43 M(-35.1%) |
| Dec 2020 | $147.09 M(-55.1%) | $147.09 M(+73.4%) |
| Sep 2020 | - | $84.83 M(-62.6%) |
| Jun 2020 | - | $226.67 M(-27.1%) |
| Mar 2020 | - | $311.07 M(-5.1%) |
| Dec 2019 | $327.65 M(+617.8%) | $327.65 M(-4.7%) |
| Sep 2019 | - | $343.82 M(+85.6%) |
| Jun 2019 | - | $185.29 M(+305.9%) |
| Dec 2018 | $45.65 M(+344.4%) | $45.65 M |
| Dec 2017 | $10.27 M | - |
FAQ
- What is SpringWorks Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual cash & cash equivalents year-on-year change?
- What is SpringWorks Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly cash and cash equivalents year-on-year change?
What is SpringWorks Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SWTX is $69.75 M
What is the all time high annual cash & cash equivalents for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual cash & cash equivalents is $327.65 M
What is SpringWorks Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SWTX annual cash & cash equivalents has changed by -$106.30 M (-60.38%)
What is SpringWorks Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SWTX is $69.75 M
What is the all time high quarterly cash and cash equivalents for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly cash and cash equivalents is $476.43 M
What is SpringWorks Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SWTX quarterly cash and cash equivalents has changed by -$10.15 M (-12.70%)